A survey of clarithromycin monotherapy and long‐term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims-Reference-Cited by-同舟云学术

A survey of clarithromycin monotherapy and long‐term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims

Published:2019-12-25 Issue:4 Volume:29 Page:427-432
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Iwao Tomohide¹²^ORCID,Kato Genta³,Ito Isao⁴,Aramaki Eiji¹,Kuroda Tomohiro²

Affiliation:

1. Institute for Research InitiativesNara Institute of Science and Technology Ikoma Japan

2. Division of Medical Information Technology and Administration PlanningKyoto University Hospital Kyoto Japan

3. Solutions Center for Health Insurance ClaimsKyoto University Hospital Kyoto Japan

4. Department of Respiratory Medicine, Graduate School of MedicineKyoto University Kyoto Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4951

Reference24 articles.

1. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives

2. Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan1

3. Infection withMycobacterium aviumComplex in Patients without Predisposing Conditions

4. Lack of Adherence to Evidence-based Treatment Guidelines for Nontuberculous Mycobacterial Lung Disease

5. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data;BMC Pulmonary Medicine;2023-06-20

2. Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data;2023-01-16

3. Anti-Mycobacterial Drug Resistance in Japan: How to Approach This Problem?;Antibiotics;2021-12-24